<p>Edge Capital Group LLC 在最近向证券交易委员会的披露中表示，在第四季度将其在礼来公司的股份减少了 12.0%。该机构投资者在此期间出售了 1,435 股后，持有该公司 10,509 股股票。Edge Capital Group LLC 在礼来公司的持股在最近的报告期末价值为 8,113,000 美元。</p>
<p>获取 <strong>礼来公司</strong> 的提醒：</p>
<ul>
<li>Biogen 股票正在转变为价值投资</li>
</ul>
<p>其他几家大型投资者最近也买卖了该公司的股票。Pathway Financial Advisers LLC 在第三季度将其在礼来公司的持仓增加了 92,759.9%。Pathway Financial Advisers LLC 目前拥有 1,022,388 股该公司的股票，价值 905,774,000 美元，此前在上个季度额外购买了 1,021,287 股。Integrated Investment Consultants LLC 在第三季度将其在礼来公司的持仓增加了 37,140.7%。Integrated Investment Consultants LLC 目前拥有 694,167 股该公司的股票，价值 614,990,000 美元，此前在上个季度额外购买了 692,303 股。Strategic Financial Concepts LLC 在第四季度将其在礼来公司的股份增加了 126,531.5%。Strategic Financial Concepts LLC 目前拥有 678,745 股该公司的股票，价值 523,991,000 美元，此前在上个季度额外购买了 678,209 股。Mizuho Securities USA LLC 在第三季度将其在礼来公司的持仓增加了 599.9%。Mizuho Securities USA LLC 目前拥有 430,853 股该公司的股票，价值 381,710,000 美元，此前在上个季度额外购买了 369,293 股。最后，Holocene Advisors LP 在第三季度将其在礼来公司的持仓增加了 257.1%。Holocene Advisors LP 目前拥有 437,603 股该公司的股票，价值 387,690,000 美元，此前在上个季度额外购买了 315,065 股。机构投资者和对冲基金持有该公司 82.53% 的股份。</p>
<h2>分析师评级变动</h2>
<p>LLY 最近成为多份研究分析师报告的主题。Redburn Atlantic 在 11 月 4 日的报告中将礼来公司评级上调至 “持有”。Berenberg Bank 在 1 月 16 日的研究报告中对礼来公司设定了 970.00 美元的目标价。Barclays 在 10 月 31 日的报告中将礼来公司的目标价从 1,025.00 美元下调至 975.00 美元，并对该公司设定了 “增持” 评级。Leerink Partners 在 1 月 17 日的研究报告中对礼来公司的股票设定了 950.00 美元的目标价。最后，Wolfe Research 在 11 月 15 日的研究报告中开始覆盖礼来公司的股票。他们对该公司设定了 “跑赢大盘” 评级和 1,000.00 美元的目标价。三位分析师对该股票给予了持有评级，十八位分析师对该股票给予了买入评级。根据 MarketBeat 的数据，礼来公司目前的共识评级为 “适度买入”，共识目标价为 1,000.28 美元。</p>
<ul>
<li>Hims \u0026 Hers 的收益可能会改变游戏规则——现在该怎么办</li>
</ul>
<p><strong>查看我们关于礼来公司的最新股票报告</strong></p>
<h2>礼来公司股价上涨 0.1%</h2>
<p>礼来公司的 LLY 股票周一开盘价为 874.12 美元。该公司的市值为 8288.2 亿美元，市盈率为 74.65，市盈增长比率为 1.40，贝塔值为 0.42。礼来公司的 1 年最低价为 711.40 美元，1 年最高价为 972.53 美元。该公司的债务与股本比率为 2.00，流动比率为 1.15，速动比率为 0.97。该公司的 50 日移动平均线为 801.33 美元，200 日移动平均线为 847.66 美元。</p>
<ul>
<li>诺和诺德股票接近新 52 周低点：分析师看到大幅上涨空间</li>
</ul>
<p>礼来公司（NYSE:LLY - 获取免费报告）最后一次发布季度收益数据是在 2 月 6 日，报告每股收益为 5.32 美元，低于共识预期的 5.45 美元（差额为 0.13 美元）。礼来公司的净利润率为 23.51%，股本回报率为 85.24%。整体来看，卖方分析师预计礼来公司在本年度的每股收益将达到 23.48 美元。</p>
<p>礼来公司宣布其董事会于 12 月 9 日启动了一项股票回购计划，允许公司回购 150 亿美元的股票。该回购授权允许公司通过公开市场购买最多 2% 的股票。股票回购计划通常表明公司的领导层认为其股票被低估。</p>
<h2>礼来公司增加股息</h2>
<p>该公司还最近宣布了一项季度股息，将于 3 月 10 日支付。2 月 14 日的股东将获得每股 1.50 美元的股息。除息日期为 2 月 14 日。这是礼来公司之前每季度股息 1.30 美元的积极变化。这代表每年 6.00 美元的股息，收益率为 0.69%。礼来公司的派息比率目前为 51.24%。</p>
<h2>礼来公司简介</h2>
<p>（免费报告）</p>
<p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素利普罗、胰岛素利普罗原料、胰岛素利普罗混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用于糖尿病；Jardiance、Mounjaro 和 Trulicity 用于 2 型糖尿病；以及 Zepbound 用于肥胖。</p>
<h2>推荐故事</h2>
<ul>
<li>我们更看好的五只股票，胜过礼来公司</li>
<li>一些值得购买的大型股有哪些？</li>
<li>5 只标普 500 股息股票即将回报投资者</li>
<li>ESG 股票，投资者需要知道什么</li>
<li>为什么 Genuine Parts Company 现在是一个非常好的购买选择</li>
<li>如何寻找被低估的股票</li>
<li>工业股悄然超越市场：3 只值得关注的股票</li>
</ul>
<p><strong>想知道其他对 LLY 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取礼来公司（NYSE:LLY - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
<p>在考虑礼来公司之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而礼来公司并不在名单上。</p>
<p>虽然礼来公司目前在分析师中获得了 “适度买入” 的评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

礼来

<p>Edge Capital Group LLC 在第四季度减少了对礼来的持股，减幅为 12%，目前持有 10,509 股，价值为 811 万美元。其他投资者，包括 Pathway Financial Advisers LLC 和 Integrated Investment Consultants LLC，显著增加了他们的持仓。分析师对 LLY 的共识评级为 “适度买入”，目标价为 1,000.28 美元。该股票开盘价为 874.12 美元，市值为 8,288.2 亿美元。礼来的最新财报显示每股收益为 5.32 美元，未达到预期，公司宣布了一项 150 亿美元的股票回购计划</p>

<p>Edge Capital Group LLC cut its stake in Eli Lilly and Company (NYSE:LLY - Free Report) by 12.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,509 shares of the company's stock after selling 1,435 shares during the period. Edge Capital Group LLC's holdings in Eli Lilly and Company were worth $8,113,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Edge Capital Group LLC 在最近向证券交易委员会的披露中表示，在第四季度将其在礼来公司的股份减少了 12.0%。该机构投资者在此期间出售了 1,435 股后，持有该公司 10,509 股股票。Edge Capital Group LLC 在礼来公司的持股在最近的报告期末价值为 8,113,000 美元。</p>
</div><p>Get <strong>Eli Lilly and Company</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>礼来公司</strong> 的提醒：</p>
</div><ul>
<li>Biogen Stock Is Mutating Into a Value Play</li>
</ul>
<div class="lb-trans"><ul>
<li>Biogen 股票正在转变为价值投资</li>
</ul>
</div><p>Several other large investors also recently bought and sold shares of the company. Pathway Financial Advisers LLC boosted its position in Eli Lilly and Company by 92,759.9% during the third quarter. Pathway Financial Advisers LLC now owns 1,022,388 shares of the company's stock worth $905,774,000 after acquiring an additional 1,021,287 shares during the last quarter. Integrated Investment Consultants LLC lifted its position in Eli Lilly and Company by 37,140.7% during the 3rd quarter. Integrated Investment Consultants LLC now owns 694,167 shares of the company's stock worth $614,990,000 after acquiring an additional 692,303 shares in the last quarter. Strategic Financial Concepts LLC lifted its position in shares of Eli Lilly and Company by 126,531.5% during the fourth quarter. Strategic Financial Concepts LLC now owns 678,745 shares of the company's stock worth $523,991,000 after purchasing an additional 678,209 shares in the last quarter. Mizuho Securities USA LLC boosted its position in Eli Lilly and Company by 599.9% in the 3rd quarter. Mizuho Securities USA LLC now owns 430,853 shares of the company's stock valued at $381,710,000 after buying an additional 369,293 shares during the last quarter. Finally, Holocene Advisors LP boosted its holdings in Eli Lilly and Company by 257.1% in the third quarter. Holocene Advisors LP now owns 437,603 shares of the company's stock valued at $387,690,000 after purchasing an additional 315,065 shares during the last quarter. Institutional investors and hedge funds own 82.53% of the company's stock.</p>
<div class="lb-trans"><p>其他几家大型投资者最近也买卖了该公司的股票。Pathway Financial Advisers LLC 在第三季度将其在礼来公司的持仓增加了 92,759.9%。Pathway Financial Advisers LLC 目前拥有 1,022,388 股该公司的股票，价值 905,774,000 美元，此前在上个季度额外购买了 1,021,287 股。Integrated Investment Consultants LLC 在第三季度将其在礼来公司的持仓增加了 37,140.7%。Integrated Investment Consultants LLC 目前拥有 694,167 股该公司的股票，价值 614,990,000 美元，此前在上个季度额外购买了 692,303 股。Strategic Financial Concepts LLC 在第四季度将其在礼来公司的股份增加了 126,531.5%。Strategic Financial Concepts LLC 目前拥有 678,745 股该公司的股票，价值 523,991,000 美元，此前在上个季度额外购买了 678,209 股。Mizuho Securities USA LLC 在第三季度将其在礼来公司的持仓增加了 599.9%。Mizuho Securities USA LLC 目前拥有 430,853 股该公司的股票，价值 381,710,000 美元，此前在上个季度额外购买了 369,293 股。最后，Holocene Advisors LP 在第三季度将其在礼来公司的持仓增加了 257.1%。Holocene Advisors LP 目前拥有 437,603 股该公司的股票，价值 387,690,000 美元，此前在上个季度额外购买了 315,065 股。机构投资者和对冲基金持有该公司 82.53% 的股份。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>LLY has been the subject of a number of research analyst reports. Redburn Atlantic upgraded Eli Lilly and Company to a &#34;hold&#34; rating in a report on Monday, November 4th. Berenberg Bank set a $970.00 target price on Eli Lilly and Company in a research note on Thursday, January 16th. Barclays reduced their target price on Eli Lilly and Company from $1,025.00 to $975.00 and set an &#34;overweight&#34; rating for the company in a report on Thursday, October 31st. Leerink Partners set a $950.00 target price on shares of Eli Lilly and Company in a research note on Friday, January 17th. Finally, Wolfe Research started coverage on shares of Eli Lilly and Company in a research report on Friday, November 15th. They set an &#34;outperform&#34; rating and a $1,000.00 target price for the company. Three analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the stock. According to data from MarketBeat, Eli Lilly and Company presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $1,000.28.</p>
<div class="lb-trans"><p>LLY 最近成为多份研究分析师报告的主题。Redburn Atlantic 在 11 月 4 日的报告中将礼来公司评级上调至 “持有”。Berenberg Bank 在 1 月 16 日的研究报告中对礼来公司设定了 970.00 美元的目标价。Barclays 在 10 月 31 日的报告中将礼来公司的目标价从 1,025.00 美元下调至 975.00 美元，并对该公司设定了 “增持” 评级。Leerink Partners 在 1 月 17 日的研究报告中对礼来公司的股票设定了 950.00 美元的目标价。最后，Wolfe Research 在 11 月 15 日的研究报告中开始覆盖礼来公司的股票。他们对该公司设定了 “跑赢大盘” 评级和 1,000.00 美元的目标价。三位分析师对该股票给予了持有评级，十八位分析师对该股票给予了买入评级。根据 MarketBeat 的数据，礼来公司目前的共识评级为 “适度买入”，共识目标价为 1,000.28 美元。</p>
</div><ul>
<li>Hims &amp; Hers Earnings Could Be a Game Changer—What to Do Now</li>
</ul>
<div class="lb-trans"><ul>
<li>Hims \u0026 Hers 的收益可能会改变游戏规则——现在该怎么办</li>
</ul>
</div><p><strong>View Our Latest Stock Report on Eli Lilly and Company</strong></p>
<div class="lb-trans"><p><strong>查看我们关于礼来公司的最新股票报告</strong></p>
</div><h2>Eli Lilly and Company Trading Up 0.1 %</h2>
<div class="lb-trans"><h2>礼来公司股价上涨 0.1%</h2>
</div><p>Shares of LLY stock opened at $874.12 on Monday. The stock has a market capitalization of $828.82 billion, a PE ratio of 74.65, a P/E/G ratio of 1.40 and a beta of 0.42. Eli Lilly and Company has a 1-year low of $711.40 and a 1-year high of $972.53. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.15 and a quick ratio of 0.97. The business has a 50-day moving average of $801.33 and a 200 day moving average of $847.66.</p>
<div class="lb-trans"><p>礼来公司的 LLY 股票周一开盘价为 874.12 美元。该公司的市值为 8288.2 亿美元，市盈率为 74.65，市盈增长比率为 1.40，贝塔值为 0.42。礼来公司的 1 年最低价为 711.40 美元，1 年最高价为 972.53 美元。该公司的债务与股本比率为 2.00，流动比率为 1.15，速动比率为 0.97。该公司的 50 日移动平均线为 801.33 美元，200 日移动平均线为 847.66 美元。</p>
</div><ul>
<li>Novo Nordisk Shares Near New 52-Week Low: Analysts See Big Upside</li>
</ul>
<div class="lb-trans"><ul>
<li>诺和诺德股票接近新 52 周低点：分析师看到大幅上涨空间</li>
</ul>
</div><p>Eli Lilly and Company (NYSE:LLY - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The company reported $5.32 earnings per share for the quarter, missing the consensus estimate of $5.45 by ($0.13). Eli Lilly and Company had a net margin of 23.51% and a return on equity of 85.24%. As a group, sell-side analysts anticipate that Eli Lilly and Company will post 23.48 earnings per share for the current year.</p>
<div class="lb-trans"><p>礼来公司（NYSE:LLY - 获取免费报告）最后一次发布季度收益数据是在 2 月 6 日，报告每股收益为 5.32 美元，低于共识预期的 5.45 美元（差额为 0.13 美元）。礼来公司的净利润率为 23.51%，股本回报率为 85.24%。整体来看，卖方分析师预计礼来公司在本年度的每股收益将达到 23.48 美元。</p>
</div><p>Eli Lilly and Company announced that its board has initiated a share buyback plan on Monday, December 9th that permits the company to buyback $15.00 billion in shares. This buyback authorization permits the company to repurchase up to 2% of its stock through open market purchases. Stock buyback plans are often an indication that the company's leadership believes its stock is undervalued.</p>
<div class="lb-trans"><p>礼来公司宣布其董事会于 12 月 9 日启动了一项股票回购计划，允许公司回购 150 亿美元的股票。该回购授权允许公司通过公开市场购买最多 2% 的股票。股票回购计划通常表明公司的领导层认为其股票被低估。</p>
</div><h2>Eli Lilly and Company Increases Dividend</h2>
<div class="lb-trans"><h2>礼来公司增加股息</h2>
</div><p>The business also recently announced a quarterly dividend, which will be paid on Monday, March 10th. Shareholders of record on Friday, February 14th will be paid a dividend of $1.50 per share. The ex-dividend date is Friday, February 14th. This is a positive change from Eli Lilly and Company's previous quarterly dividend of $1.30. This represents a $6.00 dividend on an annualized basis and a yield of 0.69%. Eli Lilly and Company's payout ratio is currently 51.24%.</p>
<div class="lb-trans"><p>该公司还最近宣布了一项季度股息，将于 3 月 10 日支付。2 月 14 日的股东将获得每股 1.50 美元的股息。除息日期为 2 月 14 日。这是礼来公司之前每季度股息 1.30 美元的积极变化。这代表每年 6.00 美元的股息，收益率为 0.69%。礼来公司的派息比率目前为 51.24%。</p>
</div><h2>Eli Lilly and Company Profile</h2>
<div class="lb-trans"><h2>礼来公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.</p>
<div class="lb-trans"><p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素利普罗、胰岛素利普罗原料、胰岛素利普罗混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用于糖尿病；Jardiance、Mounjaro 和 Trulicity 用于 2 型糖尿病；以及 Zepbound 用于肥胖。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Eli Lilly and Company</li>
<li>What Are Some of the Best Large-Cap Stocks to Buy?</li>
<li>5 S&amp;P 500 Dividend Stocks Set to Reward Investors</li>
<li>ESG Stocks, What Investors Should Know</li>
<li>Why Genuine Parts Company Is a Royally Good Buy Right Now</li>
<li>How to Find Undervalued Stocks</li>
<li>Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过礼来公司</li>
<li>一些值得购买的大型股有哪些？</li>
<li>5 只标普 500 股息股票即将回报投资者</li>
<li>ESG 股票，投资者需要知道什么</li>
<li>为什么 Genuine Parts Company 现在是一个非常好的购买选择</li>
<li>如何寻找被低估的股票</li>
<li>工业股悄然超越市场：3 只值得关注的股票</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding LLY?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eli Lilly and Company (NYSE:LLY - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他对 LLY 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取礼来公司（NYSE:LLY - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=LLY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Eli Lilly and Company Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
</div><p>Before you consider Eli Lilly and Company, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑礼来公司之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而礼来公司并不在名单上。</p>
</div><p>While Eli Lilly and Company currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然礼来公司目前在分析师中获得了 “适度买入” 的评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Edge Capital Group LLC 出售了礼来公司（NYSE:LLY）的股票